Clinical Trial Update: Bisoprolol in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease [Phase 2]

View source ↗

Summary

Phase 2 trial of bisoprolol in patients with heart failure and chronic obstructive pulmonary disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Heart Failure

Drugs mentioned

• Bisoprolol (Bisoprolol)

Snippet

Sponsor: NHS Greater Glasgow and Clyde | Conditions: Heart Failure, Chronic Obstructive Pulmonary Disease | Phase 2 | Status: TERMINATED